5th Molecular Glue Drug Development Summit | Boston, MA | January 26-28, 2027
January 26 - 28, 2027 - MA USHanson Wade Conferences Limited
info@hansonwade.com
Phone:6174554188
From Revolution Medicines' landmark FDA approval of RASONQUE™ to major discovery partnerships such as the up to $1.4 billion Novartis-Orionis collaboration, molecular glues continue to generate momentum across both clinical development and early-stage innovation. Combined with rapid advances in artificial intelligence, automation, structural biology, and induced proximity therapeutics, the field is entering a new era of discovery, unlocking previously inaccessible biology and expanding the potential of molecular glues across a growing range of disease areas. As investment, scientific understanding, and translational success accelerate, the 5th Molecular Glue Drug Development Summit serves as the industry's only dedicated forum bringing together the scientists and drug developers advancing molecular glue therapeutics from early discovery through translational and clinical development. Time: 08:30 to 16:45